Our Portfolio

University of California, Irvine

Steven Schreiber, MD | California, United States

Project Overview

  • Academic/Nonprofit Organization Type
  • $130,000 Funding Amount
  • 2/1/06 — 8/28/08 Project Duration
  • Drug Discovery Program
  • In Vivo Efficacy Therapeutic Stage
  • Closed Status

University of California, Irvine

Steven Schreiber, MD | California, United States

Efficacy of the Histone Deacetylase Inhibitor, SAHA, in AD Transgenic Mice- A Proof-of-Concept Study

GET IN TOUCH